Showing results (111-120 of 697) with videos related to
Sort By:
Pageof 70
European Journal of Biochemistry|November 15, 1995
Functional consequences of the Ser334-->Pro mutation in a human factor X variant (factor XMarseille)A Bezeaud, T Miyata, D Helley, et al.Diabetologia|November 24, 2001
Subcutaneous abdominal, but not femoral fat expression of plasminogen activator inhibitor-1 (PAI-1) is related to plasma PAI-1 levels and insulin resistance and decreases after weight lossA Mavri, M C Alessi, D Bastelica, et al.Thrombosis and Haemostasis|January 23, 1992
Daytime fluctuations of plasminogen activator inhibitor 1 (PAI-1) in populations with high PAI-1 levelsI Juhan-Vague, M C Alessi, D Raccah, et al.Thrombosis and Haemostasis|October 5, 2001
Ser968Thr mutation within the A3 domain of von Willebrand factor (VWF) in two related patients leads to a defective binding of VWF to collagenA S Ribba, I Loisel, J M Lavergne, et al.Kidney International|September 1, 1995
Antiphospholipids in hemodialysis patients: relationship between lupus anticoagulant and thrombosisP Brunet, M F Aillaud, M San Marco, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|March 7, 2001
Accumulation of triglyceride-rich lipoprotein in subjects with abdominal obesity: the biguanides and the prevention of the risk of obesity (BIGPRO) 1 studyJ M Bard, M A Charles, I Juhan-Vague, et al.Clinica Chimica Acta; International Journal of Clinical Chemistry|April 30, 1990
The increased plasma Lp(a): B lipoprotein particle concentration in angina pectoris is not associated with hypofibrinolysisM C Alessi, H J Parra, P Joly, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|January 28, 1998
Metabolic determinants are much more important than genetic polymorphisms in determining the PAI-1 activity and antigen plasma concentrations: a family study with part of the Stanislas CohortM Henry, D A Tregouët, M C Alessi, et al.Stem Cells (Dayton, Ohio)|May 1, 1994
In vivo stimulation of neutrophil function by lenograstim (glycosylated rHuG-CSF) in oncohematologic patients: results of a phase I trialC Fossat, A M Stoppa, D Sainty, et al.Annals of Internal Medicine|April 1, 1990
Coronary thrombolysis: streptokinase or recombinant tissue-type plasminogen activator?D CollenPageof 70